Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Maat Pharma S.A.
Industry Sector: HealthTechnology
CEO: Hervé Affagard, EMBA
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -2.87
Exchange/Ticker 1: Euronext Paris:MAAT
Exchange/Ticker 2: N/A
Latest Market Cap: $103,822,539
BioCentury | Jun 26, 2024
Management Tracks
Arvinas, Frontier name new CFOs
Plus: Audrey Duval to lead corporate affairs at Sanofi, and updates from MOMA,
BioCentury | Mar 23, 2024
Management Tracks
Braunstein retiring as Idorsia CMO
Plus: Lys names Vounatsos chair and updates from Theolytics, BeiGene, Renibus and MaaT
BioCentury | Apr 25, 2023
Product Development
April 24 Quick Takes: Ideaya gains on uveal melanoma data
Plus: Foghorn pauses targeted degrader study and updates from bluebird, Lilly, MaaT, Biosion
BioCentury | Mar 2, 2022
Product Development
Osel readout bolsters bacterial immunotherapy pipeline
Osel data gives the microbiome-based cancer therapy field its first efficacy signal from a randomized trial
BioCentury | Jul 18, 2020
Management Tracks
Genzyme vet Modur joins Zikani; plus Scholar Rock, Poseida, Ribon, Kiadis and more
BioCentury | May 30, 2020
Management Tracks
Schneyer named Acadia CBO; plus Hansa, MaaT, iOnctura, First Light, Oligomerix, Galecto and Hyloris
BioCentury | Feb 6, 2020
Finance
Feb. 5 Financial Quick Takes: Aimmune gets $200M Nestlé investment; plus Vineti, MaaT, Kezar, Ziopharm, Ikarovec
BioCentury | Sep 13, 2019
Company News
Management tracks: Orchard, Black Diamond, ALK-Abelló, Menarini, Imvax, Rallybio, Milestone, MaaT and more
BioCentury | Mar 15, 2019
Product Development
The microbiome universe in two maps
A guide to who’s doing what in microbiome therapeutics
Items per page:
1 - 10 of 14